Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$346.68 - $397.58 $4,506 - $5,168
-13 Reduced 1.43%
894 $0
Q3 2022

Nov 03, 2022

BUY
$321.25 - $373.84 $65,535 - $76,263
204 Added 29.02%
907 $308,000
Q2 2022

Aug 09, 2022

BUY
$300.57 - $336.42 $8,716 - $9,756
29 Added 4.3%
703 $229,000
Q1 2022

May 16, 2022

BUY
$244.61 - $310.48 $164,867 - $209,263
674 New
674 $206,000
Q2 2021

Aug 13, 2021

SELL
$184.89 - $202.68 $68,039 - $74,586
-368 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$169.52 - $196.53 $26,445 - $30,658
156 Added 73.58%
368 $72,000
Q4 2020

Feb 18, 2021

SELL
$143.79 - $183.66 $112,012 - $143,071
-779 Reduced 78.61%
212 $37,000
Q3 2020

Nov 16, 2020

BUY
$140.89 - $159.9 $120,460 - $136,714
855 Added 628.68%
991 $148,000
Q2 2020

Aug 14, 2020

BUY
$125.49 - $164.68 $17,066 - $22,396
136 New
136 $21,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Eudaimonia Partners, LLC Portfolio

Follow Eudaimonia Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.